AREX Capital Management’s Chemours CC Stock Holding History

AREX Capital Management’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-15,000	Closed	-$339K	–	14
2024 Q2	$339K	Buy	+15,000	New	+$393K	0.39%	12

Other funds holding CC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

KCM

Khrom Capital Management Miami Beach, Florida $1.19B AUM 14.29% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

AREX Capital Management's CC Position: Q3 2024 in Review

AREX Capital Management sold out of Chemours (CC) in Q3 2024, closing a stake of 15,000 shares — an estimated $339K sold.

AREX Capital Management first reported a position in CC in Q2 2024 and held it in 1 quarter. The position peaked at $339K in Q2 2024. 421 funds tracked by Wall St. Rank hold CC as of Q3 2024.

AREX Capital Management reported no remaining Chemours position as of Q3 2024 after selling out during the quarter.
AREX Capital Management sold 15,000 Chemours shares in Q3 2024, an estimated $339K.
AREX Capital Management first reported a position in Chemours in Q2 2024 and held it in 1 quarter.
AREX Capital Management's Chemours position peaked at $339K in Q2 2024.
421 funds tracked by Wall St. Rank held Chemours as of Q3 2024.

Based on AREX Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.